JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, F. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 105, Issue 4, 450-457, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


CENTRAL DEPRESSANT AND ANTICONVULSANT PROPERTIES OF GLYCEROL ETHERS ISOMERIC WITH MEPHENESIN

F. M. Berger 1

1 Wallace Laboratories, Inc., New Brunswick, New Jersey

Seven ethers of glycerol isomeric with mephenesin were tested for their ability to produce paralysis, to modify electroshock seizures and to antagonize convulsions produced by strychnine, picrotoxin and tetanus toxin.

The 3-toloxy-1,2-propanediols were found to be better paralyzing agents than the corresponding 2-toloxy-1,3-propanediol isomers. Mephenesin (3-o-toloxy-1,2-propanediol) was superior to all other compounds in its paralyzing action and in its ability to relax spasm and rigidity produced by tetanus toxin.

The 2-o-toloxy-1,3-propanediol possessed greater activity in preventing electroshock seizures and in antagonizing strychnine than any of the other compounds. Differences between the compounds in their ability to antagonize picrotoxin convulsions were not well marked.

The relation between pharmacological properties and clinical efficacy of drugs of this class is discussed. The opinion is expressed that the paralyzing action is the property most closely related to the clinical effectiveness.

Submitted on April 23, 1952




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
J. E. HARRIS
PHARMACOLOGY AND TOXICOLOGY
Arch Ophthalmol, August 1, 1953; 50(2): 192 - 247.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.